deferiprone has been researched along with Myocarditis in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
Myocarditis: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Deferiprone treatment reduced iron deposition and IR in DC rats except for blood glucose." | 1.46 | Deferiprone attenuates inflammation and myocardial fibrosis in diabetic cardiomyopathy rats. ( Bao, Y; Jia, X; Jin, Q; Li, L; Liu, R; Liu, X; Xie, R; Zou, C, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zou, C | 1 |
| Liu, X | 1 |
| Xie, R | 1 |
| Bao, Y | 1 |
| Jin, Q | 1 |
| Jia, X | 1 |
| Li, L | 1 |
| Liu, R | 1 |
1 other study available for deferiprone and Myocarditis
| Article | Year |
|---|---|
Deferiprone attenuates inflammation and myocardial fibrosis in diabetic cardiomyopathy rats.
Topics: Animals; Deferiprone; Diabetic Cardiomyopathies; Dose-Response Relationship, Drug; Endomyocardial Fi | 2017 |